Medtronic (MDT) Research & Development (2014 - 2026)

Medtronic has disclosed Research & Development across 13 years of filings, most recently posting $771.0 million for Q3 2026.

• In Q3 2026, Research & Development rose 6.2% year-over-year to $771.0 million; the TTM figure through Jul 2026 stood at $2.9 billion (up 4.89% YoY), while the FY2026 annual figure was $2.9 billion, up 5.16% from the prior year.
• Research & Development came in at $771.0 million for Q3 2026 at Medtronic, up from $671.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $771.0 million in Q3 2026 to a low of $641.0 million in Q2 2023.
• Average Research & Development over 5 years is $691.0 million, with a median of $684.0 million recorded in 2025.
• The largest YoY upside for Research & Development was 11.15% in 2022 against a maximum downside of 7.73% in 2022.
• Over 5 years, Research & Development stood at $676.0 million in 2022, then rose by 3.25% to $698.0 million in 2023, then declined by 0.14% to $697.0 million in 2024, then advanced by 8.18% to $754.0 million in 2025, then rose by 2.25% to $771.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $771.0 million in Q3 2026, $671.0 million in Q2 2026, and $722.0 million in Q1 2026.